Market Place
Sourcing Support
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Divis Pharma refuses FDA inspection, lands up on the Import Alert List
Over
the last few months, several Indian and Chinese companies have been placed on
import alert for
Dr. Reddy’s expansion plans for API production
Unrelated to the inspection of
the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe
The future of API manufacturing at Dr. Reddy’s
Almost immediately after our analysis on why “Dr. Reddy’s largest API facility maybe the
